Source: BMC Cancer. Unidade: FM
Subjects: MUTAÇÃO GENÉTICA, CARCINOMA, REAÇÃO EM CADEIA POR POLIMERASE, HEPATITE B, AMPLIFICAÇÃO DE GENES, HEPATITE C, NEOPLASIAS HEPÁTICAS
ABNT
NOGUEIRA, Jeronimo A. et al. 249 TP53 mutation has high prevalence and is correlated with larger and poorly differentiated HCC in Brazilian patients. BMC Cancer, v. 9, n. 209, 2009Tradução . . Disponível em: http://www.biomedcentral.com/1471-2407/9/204. Acesso em: 14 out. 2024.APA
Nogueira, J. A., Ono-Nita, S. K., Nita, M. E., Souza, M. M. T. de, Carmo, E. P. do, Mello, E. S., et al. (2009). 249 TP53 mutation has high prevalence and is correlated with larger and poorly differentiated HCC in Brazilian patients. BMC Cancer, 9( 209). doi:10.1186/1471-2407-9-204NLM
Nogueira JA, Ono-Nita SK, Nita ME, Souza MMT de, Carmo EP do, Mello ES, Scapulatempo C, Paranaguá-Vezozzo DC, Carrilho FJ, Alves VAF. 249 TP53 mutation has high prevalence and is correlated with larger and poorly differentiated HCC in Brazilian patients [Internet]. BMC Cancer. 2009 ; 9( 209):[citado 2024 out. 14 ] Available from: http://www.biomedcentral.com/1471-2407/9/204Vancouver
Nogueira JA, Ono-Nita SK, Nita ME, Souza MMT de, Carmo EP do, Mello ES, Scapulatempo C, Paranaguá-Vezozzo DC, Carrilho FJ, Alves VAF. 249 TP53 mutation has high prevalence and is correlated with larger and poorly differentiated HCC in Brazilian patients [Internet]. BMC Cancer. 2009 ; 9( 209):[citado 2024 out. 14 ] Available from: http://www.biomedcentral.com/1471-2407/9/204